Anti-adult T-cell leukemia/lymphoma effects of indole-3-carbinol
2009

Indole-3-carbinol's Effects on Adult T-cell Leukemia

Sample size: 8 publication 10 minutes Evidence: moderate

Author Information

Author(s): Machijima Yoshiaki, Ishikawa Chie, Sawada Shigeki, Okudaira Taeko, Uchihara Jun-nosuke, Tanaka Yuetsu, Taira Naoya, Mori Naoki

Primary Institution: University of the Ryukyus

Hypothesis

The study aims to determine the potential anti-ATLL effects of indole-3-carbinol (I3C) both in vitro and in vivo.

Conclusion

I3C could be a useful chemotherapeutic agent for patients with ATLL.

Supporting Evidence

  • I3C inhibited cell viability of HTLV-1-infected T-cell lines in a dose-dependent manner.
  • I3C did not affect uninfected T-cell lines or normal peripheral blood mononuclear cells.
  • I3C induced apoptosis in HTLV-1-infected T-cell lines.
  • I3C treatment resulted in significant tumor growth inhibition in mice.
  • I3C suppressed NF-κB and AP-1 activation, which are crucial for cell survival.

Takeaway

Indole-3-carbinol, a compound found in vegetables, can help fight a type of blood cancer called adult T-cell leukemia by making the cancer cells die.

Methodology

The study involved in vitro assays on T-cell lines and in vivo experiments on mice to assess the effects of I3C on cell viability and apoptosis.

Limitations

The study primarily focuses on preclinical data, and the effects in humans remain to be fully established.

Participant Demographics

Eight patients with acute type ATLL were included in the study.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1742-4690-6-7

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication